DAG-med: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
DAG-med
NACE 86.220, Specialist medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€234,650
2024 · €241,457-€6,807
Equity
€2.1m
2024 · €1.8m+€234,650
Cash
€53,735
2024 · €15,140+€38,594
Balance sheet total
€2.8m
2024 · €2.6m+€126,895
Largest movements
Assets
- Receivables within one year +€93,689
up €93,689 (+67.9%), from €137,977 to €231,666
- Cash +€38,594
up €38,594 (+254.9%), from €15,140 to €53,735
mainly Net result for the year (+€234,650) and Depreciation (+€23,321)
Equity and liabilities
- Profit (loss) carried forward +€234,650
up €234,650 (+15.9%), from €1.5m to €1.7m
- Debts after one year -€109,546
down €109,546 (-17.6%), from €620,971 to €511,425
Income statement
- Gross operating margin -€40,599
down €40,599 (-11.7%), from €347,804 to €307,205
- Taxes -€32,371
down €32,371 (-47.6%), from €68,010 to €35,639
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€241,457
Gross operating margin
-€40,599
Depreciation
-€1,861
Other operating charges
-€396
Financial income
+€1,224
Financial charges
+€2,455
Taxes
+€32,371
Result 2025
€234,650
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€170,231
Investment
-€23,882
Financing
-€107,754
Cash 2024
€15,140
From operations (derived)
+€170,231
Net result for the year
+€234,650
Depreciation
+€23,321
Receivables within one year
-€93,689
Deferred charges and accrued income
+€5,950
Investment (derived)
-€23,882
Investment in fixed assets (net)
-€23,882
Financing
-€107,754
Debts after one year
-€109,546
Current portion of long-term debt
+€1,791
Cash 2025
€53,735
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,642,222 | €2,769,117 | +€126,895 | +4.8% |
| Fixed assets | 21/28 | €2,094,365 | €2,094,926 | +€561 | 0.0% |
| Tangible fixed assets | 22/27 | €588,494 | €565,173 | -€23,321 | -4.0% |
| Land and buildings | 22 | €564,587 | €545,606 | -€18,981 | -3.4% |
| Plant, machinery and equipment | 23 | €15,633 | €13,656 | -€1,977 | -12.6% |
| Furniture and vehicles | 24 | €8,275 | €5,912 | -€2,362 | -28.6% |
| Financial fixed assets | 28 | €1,505,871 | €1,529,753 | +€23,882 | +1.6% |
| Current assets | 29/58 | €547,857 | €674,191 | +€126,334 | +23.1% |
| Amounts receivable within one year | 40/41 | €137,977 | €231,666 | +€93,689 | +67.9% |
| Other amounts receivable | 41 | €137,977 | €231,666 | +€93,689 | +67.9% |
| Current investments | 50/53 | €278,000 | €278,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €15,140 | €53,735 | +€38,594 | +254.9% |
| Deferred charges and accrued income | 490/1 | €116,740 | €110,790 | -€5,950 | -5.1% |
| Total equity and liabilities | 10/49 | €2,642,222 | €2,769,117 | +€126,895 | +4.8% |
| Equity | 10/15 | €1,848,007 | €2,082,657 | +€234,650 | +12.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Outside capital | 11 | €18,600 | - | -€18,600 | |
| Share premium | 1100/10 | €18,600 | - | -€18,600 | |
| Reserves | 13 | €351,110 | €351,110 | = | 0.0% |
| Non-distributable reserves | 130/1 | €279,860 | €279,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Own shares acquired | 1312 | €278,000 | €278,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €18,750 | €18,750 | = | 0.0% |
| Distributable reserves | 133 | €52,500 | €52,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,478,297 | €1,712,947 | +€234,650 | +15.9% |
| Provisions and deferred taxes | 16 | €60,000 | €60,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €60,000 | €60,000 | = | 0.0% |
| Pensions and similar obligations | 160 | €60,000 | €60,000 | = | 0.0% |
| Amounts payable | 17/49 | €734,214 | €626,460 | -€107,754 | -14.7% |
| Amounts payable after more than one year | 17 | €620,971 | €511,425 | -€109,546 | -17.6% |
| Financial debts | 170/4 | €620,971 | €511,425 | -€109,546 | -17.6% |
| Amounts payable within one year | 42/48 | €113,243 | €115,035 | +€1,791 | +1.6% |
| Current portion of amounts payable after more than one year | 42 | €107,754 | €109,546 | +€1,791 | +1.7% |
| Trade debts | 44 | €5,489 | €5,489 | = | 0.0% |
| Suppliers | 440/4 | €5,489 | €5,489 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,459 | €23,321 | +€1,861 | +8.7% |
| Other operating charges | 640/8 | €4,758 | €5,154 | +€396 | +8.3% |
| Gross operating margin | 9900 | €347,804 | €307,205 | -€40,599 | -11.7% |
| Operating profit (loss) | 9901 | €321,586 | €278,730 | -€42,856 | -13.3% |
| Financial income | 75/76B | €2,436 | €3,660 | +€1,224 | +50.2% |
| Recurring financial income | 75 | €2,436 | €3,660 | +€1,224 | +50.2% |
| Financial charges | 65/66B | €14,556 | €12,101 | -€2,455 | -16.9% |
| Recurring financial charges | 65 | €14,556 | €12,101 | -€2,455 | -16.9% |
| Profit (loss) for the period before taxes | 9903 | €309,467 | €270,289 | -€39,178 | -12.7% |
| Income taxes | 67/77 | €68,010 | €35,639 | -€32,371 | -47.6% |
| Profit (loss) for the period | 9904 | €241,457 | €234,650 | -€6,807 | -2.8% |
| Profit (loss) for the period to be appropriated | 9905 | €241,457 | €234,650 | -€6,807 | -2.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.